Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$7.72 - $21.27 $8,515 - $23,460
-1,103 Reduced 6.01%
17,249 $154,000
Q3 2022

Nov 14, 2022

BUY
$13.43 - $18.74 $246,467 - $343,916
18,352 New
18,352 $261,000
Q2 2022

Aug 15, 2022

SELL
$10.26 - $20.81 $287,280 - $582,680
-28,000 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$11.53 - $19.97 $322,840 - $559,160
28,000 New
28,000 $559,000

Others Institutions Holding ACET

About Adicet Bio, Inc.


  • Ticker ACET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,030,800
  • Market Cap $36M
  • Description
  • Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...
More about ACET
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.